DOCSLIB.ORG

Controlled Substances Standard Operating Procedures Forensic Analysis Division

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Controlled Substances Standard Operating Procedures Forensic Analysis Division Controlled Substances Standard Operating Procedures Forensic Analysis Division Controlled Substances Standard Operating Procedures Forensic Analysis Division Table of Contents 1. Goals and Objectives ................................................................................................................................. 8 1.1. Goals ............................................................................................................................................. 8 1.2. Objectives ..................................................................................................................................... 8 2. Evidence Handling ................................................................................................................................... 10 2.1 Scope .......................................................................................................................................... 10 2.2. Submission of Evidence ................................................................................................................... 10 2.3. Receiving Evidence ........................................................................................................................... 10 2.4. Cases Containing Currency, Valuables, Large Items, and Bullets .................................................... 11 2.5. Cases Requiring Examination for Latent Prints ................................................................................ 12 2.6. Cases Containing Possible Biohazards ............................................................................................. 12 2.7. Return of Evidence to the Submitting Agency ................................................................................. 13 2.8. Related Documents .......................................................................................................................... 13 3. Analysis Guidelines ................................................................................................................................. 14 3.1. Scope ................................................................................................................................................ 14 3.2. Safety ............................................................................................................................................... 14 3.3. Procedure ......................................................................................................................................... 14 3.4. Sampling Guidelines ......................................................................................................................... 15 3.5. Basic Analytical Scheme (Powders, Liquids, Tar and Chunk Substance) .......................................... 17 3.6. Drug Residues .................................................................................................................................. 19 3.7. Plant Substance and Plant Substance Residues ............................................................................... 20 3.8. Tablets and Capsules – General ....................................................................................................... 22 3.9. Pharmaceutical Tablets and Capsules .............................................................................................. 22 3.10. Clandestine Tablets and Capsules .................................................................................................. 23 3.11. No Controlled Substance Identification ......................................................................................... 24 3.12. Literature and Supporting Documentation .................................................................................... 24 3.13. Related Documents ........................................................................................................................ 25 4. Case Documentation ............................................................................................................................... 26 4.1. Scope ................................................................................................................................................ 26 4.2. Contents of Case Folder ................................................................................................................... 26 4.3. Technical Review .............................................................................................................................. 26 4.4. Administrative Review ..................................................................................................................... 27 4.5. Administrative and Technical Review Issues ................................................................................... 28 Controlled Substances Standard Operating Procedures FAD-CS-SOP Issued By: Manager – Controlled Substances Issue Date: October 23, 2015 Uncontrolled When Printed Page 2 of 121 Controlled Substances Standard Operating Procedures Forensic Analysis Division 4.6. Report Modification Records ........................................................................................................... 28 4.7. Page Numbering of Examination Documents .................................................................................. 28 4.8. Related Documents .......................................................................................................................... 29 5. Controlled Substances Worksheets ........................................................................................................ 30 5.1. Scope ................................................................................................................................................ 30 5.2. Controlled Substances Examination Sheet ...................................................................................... 30 5.3. Controlled Substances Notes Sheet ................................................................................................. 34 5.4. Controlled Substances Marihuana Checklist ................................................................................... 34 5.5. Related Documents .......................................................................................................................... 35 6. Instrument Performance and Maintenance ........................................................................................... 36 6.1. Scope ................................................................................................................................................ 36 6.2. General Requirements for Analytical Instrumentation ................................................................... 36 6.3. UV/VIS Spectrophotometer ............................................................................................................. 36 6.4. FTIR Spectrometer ........................................................................................................................... 36 6.5. Gas Chromatography/Flame Ionization Detector (GC/FID) ............................................................. 37 6.6. Gas Chromatography/Mass Spectrometry (GC/MS) ....................................................................... 37 6.7. Balances ........................................................................................................................................... 38 6.8. Pipettes ............................................................................................................................................ 40 6.9. Malfunction of an Instrument, Pipet, or Balance ............................................................................ 41 6.10. Related Documents ........................................................................................................................ 41 7. Gas Chromatography (GC) for Quantitation of Codeine in Liquids ........................................................ 42 7.1. Scope ................................................................................................................................................ 42 7.2. Safety ............................................................................................................................................... 42 7.3. Equipment, Materials, and Reagents ............................................................................................... 42 7.4. Standards, Controls, and Calibration ............................................................................................... 42 7.5. Procedure ......................................................................................................................................... 45 7.6. Interpretation................................................................................................................................... 46 7.7. Estimation of the Uncertainty of Measurement (UM) .................................................................... 47 7.8. Limitations........................................................................................................................................ 47 7.9. Advantages ....................................................................................................................................... 47 7.10. Literature and Supporting Documentation .................................................................................... 48 7.11. Related Documents .......................................................................................................................
Load more

Recommended publications
  • Analysis of Drugs Manual September 2019
    Drug Enforcement Administration Office of Forensic Sciences Analysis of Drugs Manual September 2019 Date Posted: 10/23/2019 Analysis of Drugs Manual Revision: 4 Issue Date: September 5, 2019 Effective Date: September 9, 2019 Approved By: Nelson A. Santos Table of Contents CHAPTER 1 – QUALITY ASSURANCE ......................................................................... 3 CHAPTER 2 – EVIDENCE ANALYSIS ......................................................................... 93 CHAPTER 3 – FIELD ASSISTANCE .......................................................................... 165 CHAPTER 4 – FINGERPRINT AND SPECIAL PROGRAMS ..................................... 179 Appendix 1A – Definitions ........................................................................................... 202 Appendix 1B – Acronyms and Abbreviations .............................................................. 211 Appendix 1C – Instrument Maintenance Schedule ..................................................... 218 Appendix 1D – Color Test Reagent Preparation and Procedures ............................... 224 Appendix 1E – Crystal and Precipitate Test Reagent Preparation and Procedures .... 241 Appendix 1F – Thin Layer Chromatography................................................................ 250 Appendix 1G – Qualitative Method Modifications ........................................................ 254 Appendix 1H – Analytical Supplies and Services ........................................................ 256 Appendix 2A – Random Sampling Procedures
    [Show full text]
  • GRANADA FEI Passport No: 104DK01/ITA
    DECISION of the FEI TRIBUNAL dated 14 July 2017 Positive Anti-Doping Case No.: 2016/BS09 Horse: GRANADA FEI Passport No: 104DK01/ITA Person Responsible/NF/ID: Allegra Ieraci/ITA/10097333 Represented by: Studio Legale Avv. Claudio Brugnatelli, Strada Nuova n. 53, 27100 Pavia, Italy Event/ID: CSI3*-W – El Jadida (MAR) - 2016_CI_0722_S_S_01 Date: 13 – 16 October 2016 Prohibited Substances: Oripavine, Morphine and Codeine I. COMPOSITION OF PANEL Mr. Erik Elstad, one member panel II. SUMMARY OF THE FACTS 1. Memorandum of case: By Legal Department. 2. Summary information provided by Person Responsible (PR): The FEI Tribunal duly took into consideration all evidence, submissions and documents presented in the case file, as well as during the oral hearing, as also made available by and to the PR. 3. Oral hearing: 6 July 2017 – via telephone conference call. Present: The FEI Tribunal Panel Ms. Erika Riedl, FEI Tribunal Clerk For the PR: Mr. Claudio Brugnatelli, Legal Counsel Mr. Giovanni Ieraci, PR’s father Page 1 of 19 For the FEI: Ms. Anna Thorstenson, FEI Legal Counsel III. DESCRIPTION OF THE CASE FROM THE LEGAL VIEWPOINT 1. Articles of the Statutes/Regulations which are applicable: Statutes 23rd edition, effective 29 April 2015 (“Statutes”), Arts. 1.4, 38 and 39. General Regulations, 23rd edition, 1 January 2009, updates effective 1 January 2016, Arts. 118, 143.1, 161, 168 and 169 (“GRs”). Internal Regulations of the FEI Tribunal, 2nd edition, 1 January 2012 (“IRs”). FEI Equine Anti-Doping and Controlled Medication Regulations ("EADCMRs"), 2nd edition, effective 1 January 2016. FEI Equine Anti-Doping Rules ("EAD Rules"), 2nd edition, effective 1 January 2016.
    [Show full text]
  • By HENRYDEANE, F.L.S., and HENRYB
    View Article Online / Journal Homepage / Table of Contents for this issue 34 DEASE AND BRADY ON MICROSCOPICAL VIIP.-On ikIicroscopicu2 Research in relation to Pharmacy. By HENRYDEANE, F.L.S., and HENRYB. BRADY,F.L.S. [Read at the Bath Meeting of the British Pharmaceutical Conference, Sept., 1864.1 WE have chosen for the particular subject of the present commu- nication the various preparations of opium. Whether regarded in respect to their importance in the practice of medicine, their variability in strength and character, or the peculiar conditions in which the active matter exists in the crude drug, no better subject could be found for the purpose in view. Opium, as is well known, is an extremely composite substance, being a pasty mass formed of resinous, gummy, extractive and albuminous matters, containing a larger or srrialler percentage of certain active principles diffused through it. These principles are morphine, narcotine (with its two homologuesj, codeine, narceine, mecoiiine, thellaine, and papaverine, either existing free or in com- bination with meconic, sulphuric, or other acids, the sum of the crystalline constituents, exclusive of inorganic salts, contained in good samples of the drug, being from twenty to thirty per cent. of its entire weight. Any preparation, exactly to represent opium, must contain the whole of' these principles, as indeed the tincture may be said fairly to do. It, has, however, been shown that some of the principles are inert, and others even deleterious in their action, and we have Published on 01 January 1865. Downloaded by University of Pittsburgh 30/10/2014 05:40:05.
    [Show full text]
  • For Peer Review 19 Studies
    Drug Testing and Analysis A review of chemical ‘spot’ tests: a presumptive illicit drug identification technique Journal:For Drug Peer Testing and Analysis Review Manuscript ID DTA-17-0289.R1 Wiley - Manuscript type: Review Date Submitted by the Author: n/a Complete List of Authors: Philp, Morgan; University of Technology Sydney, Centre for Forensic Science Fu, Shanlin; University of Technology Sydney, Centre for Forensic Science presumptive identification, color test, new psychoactive substances, Keywords: chemistry Chemical ‘spot’ tests are a presumptive illicit drug identification technique commonly used by law enforcement, border security personnel, and forensic laboratories. The simplicity, low cost and rapid results afforded by these tests make them particularly attractive for presumptive identification globally. In this paper, we review the development of these long- established methods and discuss color test recommendations and guidelines. A search of the scientific literature revealed the chemical Abstract: reactions occurring in many color tests are either not actively investigated or reported as unknown. Today, color tests face many challenges, from the appearance of new psychoactive substances to concerns regarding selectivity, sensitivity, and safety. Advances in technology have seen color test reagents used in digital image color analysis, solid sensors and microfluidic devices for illicit drug detection. This review aims to summarize current research and suggest the future of presumptive color testing. http://mc.manuscriptcentral.com/dta Page 1 of 34 Drug Testing and Analysis 1 2 3 A review of chemical ‘spot’ tests: a presumptive illicit drug identification 4 5 technique 6 7 Morgan Philp and Shanlin Fu 8 9 10 11 Short title: Review of chemical spot tests for illicit drug detection 12 13 Chemical ‘spot’ tests are a presumptive illicit drug identification technique commonly used 14 by law enforcement, border security personnel, and forensic laboratories.
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases Chemicals Found in Papaver Somniferum
    Dr. Duke's Phytochemical and Ethnobotanical Databases Chemicals found in Papaver somniferum Activities Count Chemical Plant Part Low PPM High PPM StdDev Refernce Citation 0 (+)-LAUDANIDINE Fruit -- 0 (+)-RETICULINE Fruit -- 0 (+)-RETICULINE Latex Exudate -- 0 (-)-ALPHA-NARCOTINE Inflorescence -- 0 (-)-NARCOTOLINE Inflorescence -- 0 (-)-SCOULERINE Latex Exudate -- 0 (-)-SCOULERINE Plant -- 0 10-HYDROXYCODEINE Latex Exudate -- 0 10-NONACOSANOL Latex Exudate Chemical Constituents of Oriental Herbs (3 diff. books) 0 13-OXOCRYPTOPINE Plant -- 0 16-HYDROXYTHEBAINE Plant -- 0 20-HYDROXY- Fruit 36.0 -- TRICOSANYLCYCLOHEXA NE 0 4-HYDROXY-BENZOIC- Pericarp -- ACID 0 4-METHYL-NONACOSANE Fruit 3.2 -- 0 5'-O- Plant -- DEMETHYLNARCOTINE 0 5-HYDROXY-3,7- Latex Exudate -- DIMETHOXYPHENANTHRE NE 0 6- Plant -- ACTEONLYDIHYDROSANG UINARINE 0 6-METHYL-CODEINE Plant Father Nature's Farmacy: The aggregate of all these three-letter citations. 0 6-METHYL-CODEINE Fruit -- 0 ACONITASE Latex Exudate -- 32 AESCULETIN Pericarp -- 3 ALANINE Seed 11780.0 12637.0 0.5273634907250652 -- Activities Count Chemical Plant Part Low PPM High PPM StdDev Refernce Citation 0 ALKALOIDS Latex Exudate 50000.0 250000.0 ANON. 1948-1976. The Wealth of India raw materials. Publications and Information Directorate, CSIR, New Delhi. 11 volumes. 5 ALLOCRYPTOPINE Plant Father Nature's Farmacy: The aggregate of all these three-letter citations. 15 ALPHA-LINOLENIC-ACID Seed 1400.0 5564.0 -0.22115561650586155 -- 2 ALPHA-NARCOTINE Plant Jeffery B. Harborne and H. Baxter, eds. 1983. Phytochemical Dictionary. A Handbook of Bioactive Compounds from Plants. Taylor & Frost, London. 791 pp. 17 APOMORPHINE Plant Father Nature's Farmacy: The aggregate of all these three-letter citations. 0 APOREINE Fruit -- 0 ARABINOSE Fruit ANON.
    [Show full text]
  • The Development of Novel Optical Screening Tests for the Presumptive Identification of New Psychoactive Substances (NPS) in Seized Illicit Materials
    The development of novel optical screening tests for the presumptive identification of New Psychoactive Substances (NPS) in seized illicit materials Morgan Philp A thesis submitted for the Degree of Doctor of Philosophy (Science) University of Technology Sydney July 2018 This page intentionally left blank Certificate of original authorship I certify that the work in this thesis has not previously been submitted for a degree nor has it been submitted as part of requirements for a degree except as part of the collaborative doctoral degree and/or fully acknowledged within the text. I also certify that the thesis has been written by me. Any help that I have received in my research work and the preparation of the thesis itself has been acknowledged. In addition, I certify that all information sources and literature used are indicated in the thesis. This research is supported by an Australian Government Research Training Program Scholarship. Production Note: ________________________________Signature removed prior to publication. __________________________25/07/2018 Morgan Philp Date iii Acknowledgements Acknowledgements This thesis could not have been completed without the support I received from many others in my work and personal life and I would like to take this opportunity to extend my gratitude to all those people here. To my supervisor Shanlin, your calm, caring and generous nature always kept me level-headed. I value the trust you placed in me throughout my PhD from project direction to representing our research group overseas. Your continued encouragement and support did not go unnoticed and I have nothing but good memories of my time as your student and I will be forever grateful that I chose your Honours project in 2012 all those years ago.
    [Show full text]
  • Determination of Morphine Content in Turkish Type Poppy Seed by Hplc Method
    DETERMINATION OF MORPHINE AND TOTAL PHENOLIC CONTENT IN POPPY SEED OF TURKISH ORIGIN A THESIS SUBMITTED TO THE GRADUATE SCHOOL OF NATURAL AND APPLIED SCIENCES OF MIDDLE EAST TECHNĠCAL UNIVERSITY BY ALĠ GEVENKĠRĠġ IN PARTIAL FULLFILMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE IN CHEMISTRY FEBRUARY 2011 DETERMINATION OF MORPHINE AND TOTAL PHENOLIC CONTENT IN POPPY SEED OF TURKISH ORIGIN Submitted by ALİ GEVENKİRİŞ in partial fulfillment of the requirements fort he degree of Master of Science in Chemistry Department, Middle East Technical University by, Prof. Dr. Canan Özgen -------------------- Dean, Graduate School of Natural and Applied Sciences Prof. Dr. Ġlker Özkan -------------------- Head of Department, Chemistry Assoc. Prof. Dr. Nursen ÇORUH -------------------- Supervisor, Chemistry Department, METU Examining Committe Members: Prof. Dr. Cihangir TANYELĠ -------------------- Chemistry Department, METU Assoc. Prof. Dr. Nursen ÇORUH -------------------- Supervisor, Chemistry Department, METU Prof. Dr. Ceyhan KAYRAN -------------------- Chemistry Department, METU Prof. Dr. Özdemir DOĞAN -------------------- Chemistry Department, METU Assoc. Prof. Dr. Hakan ULUKAN -------------------- Faculty of Agriculture, Field Crops Dept. Ankara University Date: / / ii I hereby declare that all information in this document has been obtained and presented in accordance with academic rules and ethical conduct. I also declare that, as required by these rules and conduct, I have fully cited and referenced all material and results that not original to the this work. Name, Last name: Ali GEVENKİRİŞ Signature: iii ABSTRACT DETERMINATION OF MORPHINE AND TOTAL PHENOLIC CONTENT IN POPPY SEED OF TURKISH ORIGIN GevenkiriĢ, Ali M.Sc.,Department of Chemistry Supervisor: Assoc. Prof. Dr. Nursen Çoruh February 2011, 51 Pages Turkey is important major licid opium poppy (Papaver Somniferum) producer for medicinal and scientific purposes in the world and one of the two traditional producer country.
    [Show full text]
  • This List Was Originally Published in Virginia Register Volume 8, Issue 18
    In accordance with 6 VAC 40-30, the Regulations for the Approval of Field Tests for Detection of Drugs, and under the authority of the Code of Virginia, the following field tests for detection of drugs are approved field tests: O D V INCORPORATED 13386 INTERNATIONAL PARKWAY JACKSONVILLE, FLORIDA 32218-2383 ODV NarcoPouch Drug or Drug Type: Manufacturer’s Field Test: Heroin 902 – Marquis Reagent Amphetamine 902 – Marquis Reagent Methamphetamine 902 – Marquis Reagent 3,4–Methylenedioxymethamphetamine (MDMA) 902 – Marquis Reagent Cocaine Hydrochloride 904 or 904B – Cocaine HCl and Base Reagent Cocaine Base 904 or 904B – Cocaine HCl and Base Reagent Barbiturates 905 – Dille-Koppanyi Reagent Lysergic Acid Diethylamide (LSD) 907 – Ehrlich’s (Modified) Reagent Marijuana 908 – Duquenois – Levine Reagent Hashish Oil 908 – Duquenois – Levine Reagent Marijuana 909 – K N Reagent Hashish Oil 909 – K N Reagent Phencyclidine (PCP) 914 – PCP Methaqualone Reagent Heroin 922 – Opiates Reagent Methamphetamine 923 – Methamphetamine/Ecstasy Reagent 3,4–Methylenedioxymethamphetamine (MDMA) 923 – Methamphetamine/Ecstasy Reagent Heroin 924 – Mecke’s (Modified) Reagent Diazepam 925 – Valium/Ketamine Reagent Ketamine 925 – Valium/Ketamine Reagent Ephedrine 927 – Ephedrine Reagent gamma – Hydroxybutyrate (GHB) 928 – GHB Reagent ODV NarcoTest Drug or Drug Type: Manufacturer’s Field Test: Heroin 7602 – Marquis Reagent Amphetamine 7602 – Marquis Reagent Methamphetamine 7602 – Marquis Reagent 3,4–Methylenedioxymethamphetamine (MDMA) 7602 – Marquis Reagent Barbiturates
    [Show full text]
  • Seized Drugs SOP 09.09.2019
    Seized Drugs Standard Operating Procedures Comparative and Analytical Division Seized Drugs Standard Operating Procedures Comparative and Analytical Division Table of Contents 1. Goals and Objectives ................................................................................................................................8 1.1. Goals.............................................................................................................................................8 1.2. Objectives.....................................................................................................................................8 2. Evidence Handling ..................................................................................................................................10 2.1 Scope..........................................................................................................................................10 2.2. Receiving and Documenting Evidence.............................................................................................10 2.3. Cases Containing Currency, Valuables, Large Items, and Bullets.....................................................12 2.4. Cases Requiring Examination for Latent Prints................................................................................12 2.5. Cases Containing Possible Biohazards .............................................................................................12 2.6. Return of Evidence to the Submitting Agency.................................................................................13
    [Show full text]
  • Risk Assessment Report of a New Psychoactive Substance: 1
    Risk Assessment Report of a new psychoactive substance: 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one (3,4-methylenedioxypyrovalerone, MDPV) In accordance with Article 6 of Council Decision 2005/387/JHA on information exchange, risk assessment and control of new psychoactive substances 1. Introduction This Risk Assessment Report presents the summary findings and the conclusions of the risk assessment carried out by the extended Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) on the new psychoactive substance 1-(1,3- benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one, commonly called 3,4- methylenedioxypyrovalerone (MDPV ). The report has been prepared and drafted in accordance with the conceptual framework and the procedure set out in the Risk assessment of new psychoactive substances: operating guidelines (1). It is written as a stand-alone document presenting a summary of the information considered during the detailed analysis of the scientific and law enforcement data available at this time. The conclusion section of the report summarises the main issues addressed and reflects the opinions held by the members of the Scientific Committee. A list of the information resources considered by the Scientific Committee, including a detailed Technical Report on MDPV, is provided below. The risk assessment has been undertaken in compliance with Article 6 of Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk assessment and control of new psychoactive substances ( 2) (hereafter the ‘Council Decision’). The Council Decision establishes a mechanism for the rapid exchange of information on new psychoactive substances (hereafter ‘Early Warning System’ ( 3)) that may pose public health and social threats, including the involvement of organised crime.
    [Show full text]
  • LXV.-On the Relation Bet Ween the Absorption Spectra and the Chemical Stmetwe of Corydaline, Ber- Berine, and Other Alkaloids
    View Article Online / Journal Homepage / Table of Contents for this issue ABSORPTION SPECTRA OF ALKALOIDS. 605 Published on 01 January 1903. Downloaded by Rensselaer Polytechnic Institute 23/10/2014 03:49:06. LXV.-On the Relation bet ween the Absorption Spectra and the Chemical Stmetwe of Corydaline, Ber- berine, and other Alkaloids. By JAMESJ. DOBBIE,M.A., D.Sc., and ALEXANDERLAUDER, B.Sc. INa paper read before the Society in December, 1901 (Trans., 1902, 81, 145), we communicated the results of our investigation on the constitution of corydaline, and showed that this alkaloid is closely related to berberine. We have since been engaged in the spectroscopic View Article Online 606 DOBBIE AND LAUDER: ABSORPTION SPECTRA AND examination of these two alkaloids and their decomposition products, and me now propose to lay the results of this supplementary investi- gation before the Society, with the object mainly of showing that the spectroscopic method might, with advantage, be generally employed in such researches, In a paper communicated to the Royal Society eighteen years ago by Professor Hartley (PM,Frans., 1885, Part 11, 471), it is shown that the principal alkaloids give highly characteristic absorption spectra which can be used for their identification and for ascertaining their purity. It is further shown that alkaloids closely related to one another, like quinine and quinidine, cinchonine and cinchonidine, mor- phine and codeine, give very similar spectra. At the time at which this paper was published, however, little progress had been made with tho investigation of the alkaloids, and it was not possible, therefore, to trace any close connection between their structure and their spectra.
    [Show full text]
  • Introduction (Pdf)
    Dictionary of Natural Products on CD-ROM This introduction screen gives access to (a) a general introduction to the scope and content of DNP on CD-ROM, followed by (b) an extensive review of the different types of natural product and the way in which they are organised and categorised in DNP. You may access the section of your choice by clicking on the appropriate line below, or you may scroll through the text forwards or backwards from any point. Introduction to the DNP database page 3 Data presentation and organisation 3 Derivatives and variants 3 Chemical names and synonyms 4 CAS Registry Numbers 6 Diagrams 7 Stereochemical conventions 7 Molecular formula and molecular weight 8 Source 9 Importance/use 9 Type of Compound 9 Physical Data 9 Hazard and toxicity information 10 Bibliographic References 11 Journal abbreviations 12 Entry under review 12 Description of Natural Product Structures 13 Aliphatic natural products 15 Semiochemicals 15 Lipids 22 Polyketides 29 Carbohydrates 35 Oxygen heterocycles 44 Simple aromatic natural products 45 Benzofuranoids 48 Benzopyranoids 49 1 Flavonoids page 51 Tannins 60 Lignans 64 Polycyclic aromatic natural products 68 Terpenoids 72 Monoterpenoids 73 Sesquiterpenoids 77 Diterpenoids 101 Sesterterpenoids 118 Triterpenoids 121 Tetraterpenoids 131 Miscellaneous terpenoids 133 Meroterpenoids 133 Steroids 135 The sterols 140 Aminoacids and peptides 148 Aminoacids 148 Peptides 150 β-Lactams 151 Glycopeptides 153 Alkaloids 154 Alkaloids derived from ornithine 154 Alkaloids derived from lysine 156 Alkaloids
    [Show full text]